1. Home
  2. USNA vs UPB Comparison

USNA vs UPB Comparison

Compare USNA & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • UPB
  • Stock Information
  • Founded
  • USNA 1992
  • UPB 2021
  • Country
  • USNA United States
  • UPB United States
  • Employees
  • USNA N/A
  • UPB N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • UPB
  • Sector
  • USNA Health Care
  • UPB
  • Exchange
  • USNA Nasdaq
  • UPB NYSE
  • Market Cap
  • USNA 565.2M
  • UPB 521.3M
  • IPO Year
  • USNA 1996
  • UPB 2024
  • Fundamental
  • Price
  • USNA $32.77
  • UPB $11.20
  • Analyst Decision
  • USNA Hold
  • UPB Strong Buy
  • Analyst Count
  • USNA 1
  • UPB 4
  • Target Price
  • USNA $36.00
  • UPB $56.50
  • AVG Volume (30 Days)
  • USNA 157.7K
  • UPB 500.3K
  • Earning Date
  • USNA 07-22-2025
  • UPB 08-14-2025
  • Dividend Yield
  • USNA N/A
  • UPB N/A
  • EPS Growth
  • USNA N/A
  • UPB N/A
  • EPS
  • USNA 1.82
  • UPB N/A
  • Revenue
  • USNA $876,242,000.00
  • UPB $2,296,000.00
  • Revenue This Year
  • USNA $13.04
  • UPB N/A
  • Revenue Next Year
  • USNA $7.36
  • UPB N/A
  • P/E Ratio
  • USNA $18.04
  • UPB N/A
  • Revenue Growth
  • USNA N/A
  • UPB N/A
  • 52 Week Low
  • USNA $23.10
  • UPB $5.14
  • 52 Week High
  • USNA $48.85
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • USNA 68.33
  • UPB N/A
  • Support Level
  • USNA $30.36
  • UPB N/A
  • Resistance Level
  • USNA $31.43
  • UPB N/A
  • Average True Range (ATR)
  • USNA 0.82
  • UPB 0.00
  • MACD
  • USNA 0.18
  • UPB 0.00
  • Stochastic Oscillator
  • USNA 98.86
  • UPB 0.00

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Share on Social Networks: